<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827290</url>
  </required_header>
  <id_info>
    <org_study_id>CKD AGE</org_study_id>
    <nct_id>NCT04827290</nct_id>
  </id_info>
  <brief_title>Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease</brief_title>
  <acronym>CKD AGE</acronym>
  <official_title>Assessment of the Effect of Restriction on Alimentary AGE (Advanced Glycation Products) in Progression of Chronic Kidney Disease (CKD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Saint Joseph Saint Luc de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Saint Joseph Saint Luc de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and&#xD;
      high-AGE diet in stage IIIa-b renal failure patients&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glomerular Fitration Rate</measure>
    <time_frame>At 24 months</time_frame>
    <description>Glomerular Fitration Rate estimated by the CKD-EPI formula with a blood sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proteinuria</measure>
    <time_frame>At 24 months</time_frame>
    <description>Proteinuria (g/24h) found in the 24-hour urine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Chronic Kidney Disease stage3</condition>
  <condition>Chronic Kidney Disease Stage 3B</condition>
  <condition>Chronic Kidney Disease Stage 3A (Disorder)</condition>
  <condition>Chronic Kidney Disease, Stage 3 (Moderate)</condition>
  <condition>Diet Habit</condition>
  <arm_group>
    <arm_group_label>Normal-protein and low-AGE through raw or rare proteins diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal-protein (0,8g/kg/day) and low-AGE through raw or rare proteins diet during 24 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal-protein and AGE-rich diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal-protein (0,8g/kg/day) and high-AGE through overcooked proteins diet during 24 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-AGE diet</intervention_name>
    <description>Low-AGE diet during 24 months</description>
    <arm_group_label>Normal-protein and low-AGE through raw or rare proteins diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High-AGE diet</intervention_name>
    <description>High-AGE diet during 24 months</description>
    <arm_group_label>Normal-protein and AGE-rich diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a grade IIIA-B CKD (GFR with CKD-EPI ≥ 30 mL/min and &lt; 60mL/min)&#xD;
&#xD;
          -  Informed consent signed&#xD;
&#xD;
          -  Aged 18 to 89 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Protected adult&#xD;
&#xD;
          -  Acute renal failture&#xD;
&#xD;
          -  Patient already on a low-AGE diet (&lt; 1kU AGE/day) following a dietetic consultation&#xD;
&#xD;
          -  Current participation in another interventional research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fanny Doroszewski</last_name>
    <phone>0033478618398</phone>
    <email>fdoroszewski@chsjsl.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabrielle Normand, MD</last_name>
    <email>lgnormand@chsjsl.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Joseph Saint Luc</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Fanny Doroszewski</last_name>
      <phone>0033478618398</phone>
      <email>fdoroszewski@chsjsl.fr</email>
    </contact>
    <contact_backup>
      <last_name>Gabrielle Normand, MD</last_name>
      <email>lgnormand@chsjsl.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Gabrielle Normand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel Villar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amélie Belloi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cecile Chauvet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathilde Luce, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>kidney failure</keyword>
  <keyword>advanced glycation products</keyword>
  <keyword>chronic kidney disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

